Search

Your search keyword '"Easton, D.F. (Douglas)"' showing total 91 results

Search Constraints

Start Over You searched for: Author "Easton, D.F. (Douglas)" Remove constraint Author: "Easton, D.F. (Douglas)"
91 results on '"Easton, D.F. (Douglas)"'

Search Results

1. Personalizing Breast Cancer Screening Based on Polygenic Risk and Family History

2. Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer

3. The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With BRCA1 or BRCA2 Mutations

4. The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With BRCA1 or BRCA2 Mutations

5. Erratum: Publisher Correction: Shared heritability and functional enrichment across six solid cancers (Nature communications (2019) 10 1 (431))

6. Germline variation at 8q24 and prostate cancer risk in men of European ancestry

7. Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma

8. The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity

9. Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation

10. Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia

11. E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium

12. A somatic-mutational process recurrently duplicates germline susceptibility loci and tissue-specific super-enhancers in breast cancers

13. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

14. Genetic modifiers of CHEK2∗1100delC-associated breast cancer risk

15. Rare and low-frequency coding variants alter human adult height

16. Body mass index and breast cancer survival

17. PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1

18. Reproductive profiles and risk of breast cancer subtypes

19. TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer

20. A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease

21. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

22. Age-And tumor subtype-specific breast cancer risk estimates for CHEK2∗1100delC Carriers

23. Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21

24. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

25. Prognostic value of automated KI67 scoring in breast cancer: A centralised evaluation of 8088 patients from 10 study groups

26. High-throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium (BCAC)

27. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

28. Genetic predisposition to ductal carcinoma in situ of the breast

29. Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation

30. Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3

31. Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women

32. Fine-mapping of the 1p11.2 breast cancer susceptibility locus

33. Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent

34. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

35. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

36. Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1

37. Prediction of breast cancer risk based on profiling with common genetic variants

38. A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients

39. Identification of novel genetic markers of breast cancer survival

40. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy

41. Common germline polymorphisms associated with breast cancer-specific survival

42. Annexin A1 expression in a pooled breast cancer series: Association with tumor subtypes and prognosis

43. Crowdsourcing the General Public for Large Scale Molecular Pathology Studies in Cancer

44. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

45. Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression

46. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

47. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

48. Assessing associations between the AURKAHMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers

49. Rare coding variants and X-linked loci associated with age at menarche

50. Candidate genetic modifiers for breast and ovarian cancer risk inBRCA1andBRCA2 mutation carriers

Catalog

Books, media, physical & digital resources